Fig. 2.
A-F) Metastasis-free survival (MFS) in groups stratified by prostate-specific antigen nadir (nPSA) in 186 patients treated with EBRT combined with BT boost and ADT for localized prostate cancer
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.